نتائج البحث - "Christoph Plöger"

المصدر: HemaSphere
Kutsch, N, Bahlo, J, Robrecht, S, Franklin, J, Zhang, C, Maurer, C, De Silva, N, Lange, E, Weide, R, Kiehl, M G, Sökler, M, Schlag, R, Vehling-Kaiser, U, Köchling, G, Plöger, C, Gregor, M, Plesner, T, Herling, M, Fischer, K, Döhner, H, Kneba, M, Wendtner, C-M, Klapper, W, Kreuzer, K-A, Böttcher, S, Stilgenbauer, S, Fink, A M, Hallek, M & Eichhorst, B 2020, ' Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG) ', HemaSphere, vol. 4, no. 1, e336 . https://doi.org/10.1097/HS9.0000000000000336Test
HemaSphere, Vol 4, Iss 1, p e336 (2020)

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79798c96add92eb229586e97614faf4dTest
https://doi.org/10.1097/hs9.0000000000000336Test

4

Excellent long-term survival of 170 patients with Waldenström’s macroglobulinemia treated in private oncology practices and a university hospital

المؤلفون: H.-P. Feustel, Mathias Witzens-Harig, S. Fuxius, Jürgen Brust, Franz Mosthaf, Manfred Hensel, Christoph Plöger, A. D. Ho, J. Franz-Werner, Marie-Luise Memmer, Michael Rieger, A. Karcher, Dieter Schuster

المصدر: Annals of Hematology. 91:1923-1928

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d997e2f8efa46bb7b7767f8e9c58c1dTest
https://doi.org/10.1007/s00277-012-1545-8Test

5

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10):an international, open-label, randomised, phase 3, non-inferiority trial

المصدر: Eichhorst, B, Fink, A-M, Bahlo, J, Busch, R, Kovacs, G, Maurer, C, Lange, E, Köppler, H, Kiehl, M, Sökler, M, Schlag, R, Vehling-Kaiser, U, Köchling, G, Plöger, C, Gregor, M, Plesner, T, Trneny, M, Fischer, K, Döhner, H, Kneba, M, Wendtner, C-M, Klapper, W, Kreuzer, K-A, Stilgenbauer, S, Böttcher, S, Hallek, M & The German CLL Study group (GCLLSG) 2016, ' First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10) : an international, open-label, randomised, phase 3, non-inferiority trial ', The Lancet Oncology, vol. 17, no. 7, pp. 928-942 . https://doi.org/10.1016/S1470-2045Test(16)30051-1

مصطلحات موضوعية: Adult, Male, Bendamustine, medicine.medical_specialty, Cyclophosphamide, Population, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Chemoimmunotherapy, Obinutuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Bendamustine Hydrochloride, Humans, Medicine, education, Survival rate, Aged, Neoplasm Staging, Aged, 80 and over, education.field_of_study, business.industry, International Agencies, Middle Aged, Prognosis, Leukemia, Lymphocytic, Chronic, B-Cell, Fludarabine, Surgery, Survival Rate, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, Rituximab, Immunotherapy, business, Vidarabine, Follow-Up Studies, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757f379487ba123061e3e80fa89c7bc1Test
https://portal.findresearcher.sdu.dk/da/publications/e15d539d-e996-48a0-90ae-5d115577eb3eTest

6

Favorable Toxicity Profile and Long Term Outcome of Elderly, but Physically Fit CLL Patients (pts) Receiving First Line Bendamustine and Rituximab (BR) Frontline Chemoimmunotherapy in Comparison to Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Advanced Chronic Lymphocytic Leukemia (CLL): Update Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

المصدر: Blood. 128:4382-4382

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::74697b6f55a07360defe5533ffe963edTest
https://doi.org/10.1182/blood.v128.22.4382.4382Test

7

Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

المصدر: Eichhorst, B, Fink, A M, Busch, R, Kovacs, G, Maurer, C, Lange, E, Köppler, H, G Kiehl, M, Soekler, M, Schlag, R, Vehling-Kaiser, U, R. A. Köchling, G, Plöger, C, Gregor, M, Plesner, T, Trneny, M, Fischer, K, Döhner, H, Kneba, M, Wendtner, C-M, Klapper, W, Kreuzer, K A, Stilgenbauer, S, Böttcher, S & Hallek, M 2014, ' Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL) : Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study) ', 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, United States, 06/12/2014-09/12/2014 . < https://ash.confex.com/ash/2014/webprogram/Paper69485.htmlTest >

مصطلحات موضوعية: Bendamustine, medicine.medical_specialty, business.industry, Anemia, Incidence (epidemiology), Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, Fludarabine, Regimen, Chemoimmunotherapy, Internal medicine, medicine, Rituximab, business, IGHV@, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a79df8c3296bf9401e00cc6628bf488Test
https://doi.org/10.1182/blood.v124.21.19.19Test

8

Chemoimmunotherapy With Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Bendamustine and Rituximab (BR) In Previously Untreated and Physically Fit Patients (pts) With Advanced Chronic Lymphocytic Leukemia (CLL): Results Of a Planned Interim Analysis Of The CLL10 Trial, An International, Randomized Study Of The German CLL Study Group (GCLLSG)

المصدر: Blood. 122:526-526

مصطلحات موضوعية: Bendamustine, medicine.medical_specialty, education.field_of_study, business.industry, Immunology, Population, Hazard ratio, Cell Biology, Hematology, Neutropenia, Interim analysis, medicine.disease, Biochemistry, Gastroenterology, Fludarabine, Regimen, Chemoimmunotherapy, Internal medicine, medicine, education, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b17abe1376b2e08194a2a00f022cadc5Test
https://doi.org/10.1182/blood.v122.21.526.526Test

تنقيح النتائج